Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Clinical trial NCT02975882 · COMPLETED

Trial details

NCT number: NCT02975882
Sponsor: Children's Oncology Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Childhood Solid Neoplasm Recurrent Malignant Solid Neoplasm Recurrent Primary Central Nervous System Neoplasm Refractory Malignant Solid Neoplasm Refractory Primary Central Nervous System Neoplasm

Start date: 2017-08-15
Primary completion: 2022-03-31
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.